Navigation Links
Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer
Date:6/19/2012

LONDON, June 19, 2012 /PRNewswire/ -- The Foundation for Research on the Nervous System, Replikins Ltd., and Bioradar UK Ltd. today announced that over 100 new synthetic Replikins vaccines for infectious diseases and cancer are now available as a result of the discovery by scientists Drs. Samuel and Elenore Bogoch of the evolution of the genomic Replikins over time -- from ocean archaea to human cancer. A book on this subject will be released in September 2012.

Peak Gene Replikin Count: http://www.ereleases.com/pic/2012-Peak-Gene-Replikin-Count.jpg

Drs. Bogoch have determined that the highest peak gene Replikin Counts are six-fold greater in brain cancer than the Counts in ocean archaea and viruses. The ability to specify certain increasing genomic sequences related to lethality has permitted new synthetic vaccines for organisms such as Taura Syndrome Virus, infectious salmon anemia virus, universal influenza virus strains, highly lethal drug-resistant tuberculosis, and malaria, and cancers of histological type with the highest five-year mortality rates for which vaccines have not previously been available.

Because these Replikins genomic sequences have been shown to provide 1-2 years advance notice of outbreaks, effective synthetic vaccines have been manufactured by the Companies in seven days, providing time for adequate testing, and can be delivered in freeze-dried form in literally limitless quantities.

References

Accounts of some of the work on individual products have been published 1) in eight papers in Nature Precedings 2011-2012 (http://bit.ly/MdaG8m); 2) on the companies' website (http://www.Replikins.com), which contains over 40 news announcements from 2006-present; and 3) in patent publications from 2002-present.

Contact: Dr. S. Bogoch, 646-320-5910

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Replikins Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Australian Discovered Biomarkers Map Path to New Blood Test for Bowel Cancer
2. Novel method to make nanomaterials discovered
3. Dual-acting class of antimalarial compounds discovered with potential to prevent and treat malaria
4. Evolution Issue of the Month 2. Natural Selection--Not the Best Idea Anyone Ever Had
5. Martha Stewart Reveals the Secret Behind her Radiant Skin is Revolutionary Anti-aging BIOEFFECT EGF SERUM
6. New Revolutionary Femoral Access Site Closure Device Shows Unparalleled Efficacy, Safety & Ease of Use, in a Wide Range of Patients Including Patients With a Challenging Anatomy
7. Luminex Corporation Receives CE Mark for Revolutionary Newborn Screening Platform
8. PTV Interview Exclusive: Revolutionary GSK and J&J Participation in New Index Ventures Fund
9. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
10. Genomic Health and OncoMed Announce Strategic Alliance for Biomarker Research and Discovery Using Next Generation Sequencing
11. Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):